Cargando…
Adjuvant interferon gamma in patients with drug – resistant pulmonary tuberculosis: a pilot study
BACKGROUND: Tuberculosis (TB) is increasing in the world and drug-resistant (DR) disease beckons new treatments. METHODS: To evaluate the action of interferon (IFN) gamma as immunoadjuvant to chemotherapy on pulmonary DR-TB patients, a pilot, open label clinical trial was carried out in the Cuban re...
Autores principales: | Suárez-Méndez, Roberto, García-García, Idrian, Fernández-Olivera, Norma, Valdés-Quintana, Magalys, Milanés-Virelles, María T, Carbonell, Dalia, Machado-Molina, Delfina, Valenzuela-Silva, Carmen M, López-Saura, Pedro A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC529257/ https://www.ncbi.nlm.nih.gov/pubmed/15500691 http://dx.doi.org/10.1186/1471-2334-4-44 |
Ejemplares similares
-
Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: A randomized, double-blind, placebo-controlled study
por: Milanés-Virelles, María T, et al.
Publicado: (2008) -
Pharmacokinetic and pharmacodynamic characterization of a novel formulation containing co-formulated interferons alpha-2b and gamma in healthy male volunteers
por: García-García, Idrian, et al.
Publicado: (2016) -
Pharmacokinetic and pharmacodynamic comparison of two "pegylated" interferon alpha-2 formulations in healthy male volunteers: a randomized, crossover, double-blind study
por: García-García, Idrian, et al.
Publicado: (2010) -
Therapeutic potential of interferon-gamma in tuberculosis
por: Berns, Svetlana A., et al.
Publicado: (2022) -
Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG®) in patients with mycosis fungoides: an open-label trial
por: García-Vega, Yanelda, et al.
Publicado: (2012)